Primary aldosteronism in normokalemic patients with adrenal incidentalomas

European Journal of Endocrinology

Volumn 146, Issue 4, 2002, Pages 523-529

  Bernini, Giampaolo ^a   Moretti, Angelica ^a   Argenio, Gianfranco ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; POTASSIUM; RENIN; SODIUM CHLORIDE;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELIABILITY; SYMPTOM;

EID: 0036232001     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460523     Document Type: Article

References (56)

1. Adrenal incidentaloma: An overview of clinical and epidemiological data from the National Italian Study Group
2. A survey on adrenal incidentaloma in Italy
3. Adrenal cortical adenomas and hypertension: A clinical pathologic analysis of 690 cases with matched controls and a review of the literature
4. Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group
5. Preclinical Cushing's syndrome in adrenal incidentalomas: Comparison with adrenal Cushing's syndrome
6. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
7. Abnormalities of endocrine function in patients with clinically silent adrenal masses
8. Different pattern of steroid secretion in patients with adrenal incidentaloma
9. Incidentally discovered adrenal tumors: Endocrine and scintigraphic correlates
10. Normokaliemic primary aldosteronism. A detectable cause of curable essential hypertension
11. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 to 1975
12. Diagnosis and treatment of primary hyperaldosteronism
13. Primary aldosteronism
14. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers
15. High incidence of primary aldosteronism in 199 patients referred with hypertension
16. Screening of a population of young hypertensives for primary hyperaldosteronism
17. Unexpectedly High Prevalence of Primary Aldosteronism in a Hypertensive Population in Dundee
18. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology
19. Potentially high prevalence of primary aldosteronism in a primary-care population
20. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore
21. Mineralocorticoid hypertension
22. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: Aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene
23. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism
24. Primary aldosteronism: Update on diagnosis and treatment
25. The changing clinical spectrum of primary aldosteronism
26. Plasma renin activity in the diagnosis of primary aldosteronism: Failure to distinguish primary aldosteronism from essential hypertension
27. Plasma aldosterone-plasma renin activity ratio: A simple test to identify patients with primary hyperaldosteronism
28. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism
29. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertensive of patients
30. Primary aldosteronism: Diagnosis and treatment
31. The diagnosis of primary aldosteronism and separation of two major subtypes
32. Primary aldosteronism
33. Primary aldosteronism
34. Pheochromocytoma and primary aldosteronism: Diagnostic approaches
35. Single dose captopril as a diagnostic test for primary aldosteronism
36. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism
37. Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism
38. Saline suppression of plasma aldosterone in hypertension
39. Diagnosis of secondary forms of hypertension
40. Primary aldosteronism. Diagnostic evaluation
41. Reliability of screening methods for the diagnosis of primary aldosteronism
42. Further evaluation of saline infusion for the diagnosis of primary aldosteronism
43. Captopril suppression versus salt loading in confirming primary aldosteronism
44. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma
45. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: Results in 104 consecutive cases
46. Incidence of primary aldosteronism in uncomplicated essential hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria
47. Normotensive primary aldosteronism
48. Normotensive primary aldosteronism: Report of a case
49. Aldosterone-producing adenoma without hypertension: A report of two cases
50. Incidentalomas. A disease of modern technology
51. Hormonal evaluation of the patient with an incidentally discovered adrenal mass
52. Incidentally discovered adrenal masses
53. The clinical evaluation of silent adrenal masses
54. Clinically silent adrenal masses
55. The incidental adrenal mass